The practical decision most patients face

Most joint problems land first with a general orthopaedic surgeon — and for many patients, that is the right place to stay. General orthopaedic practice covers a broad range of musculoskeletal conditions competently, including straightforward cartilage presentations and the full spectrum of joint replacement surgery.

The question shifts when joint preservation is still a realistic goal. A dedicated cartilage specialist's scope is narrower by design — focused on techniques and technologies that go beyond what routine orthopaedic practice typically provides. The treatment portfolio at a dedicated cartilage centre may include injectable scaffold procedures, cell-based repair, osteochondral grafting, and alignment-corrective surgery — options that are not all routinely available in a general orthopaedic setting. This is not a comment on clinical quality; it is a question of subspecialty depth and treatment access.

Patients are sometimes told that joint replacement is their only option — not because all alternatives have been evaluated and ruled out, but because replacement is the most locally available route. International consensus supports considering joint preservation before replacement for suitable patients, and a cartilage specialist's role is precisely to assess whether that window remains open.

Three converging signals are worth understanding before any decision is made: patient age, lesion characteristics, and the treatment techniques a referring surgeon can realistically offer. The sections that follow unpack each one.

Why age is the sharpest trigger for a specialist opinion

Numbers from UK joint-registry data, published in The Lancet, make the timing argument concrete: a man in his early fifties faces roughly a 35% lifetime risk of needing revision joint replacement surgery, compared with approximately 5% for a patient in their seventies. That gap exists simply because a younger patient is likely to outlive the implant.

Revision surgery — replacing or repairing a joint replacement that has failed or worn out — is considerably more demanding than the original procedure. It carries higher complication rates and, on average, produces inferior functional outcomes. This is not an argument against joint replacement; it is an argument for timing it carefully. A replacement undertaken at the right age and stage remains entirely appropriate. The concern arises when it is offered prematurely to a patient who still has viable preserving options.

Age matters biologically as well as statistically. Younger patients show higher chondrogenic potential — greater capacity to produce glycosaminoglycans and collagen, and stronger responsiveness to the growth factors that drive cartilage repair. Published evidence suggests that clinical outcome scores and MRI evidence of cartilage fill are both better in younger patients following repair procedures. In other words, the window for effective cartilage intervention is open widest at exactly the age when preservation tends to be most under-explored.

For any patient under approximately 55–60 with persistent joint pain and a focal cartilage lesion, there is a clear case for at least one opinion from a specialist who can assess whether a preserving route remains available before a replacement is agreed.

Defect size and grade as clinical thresholds

Cartilage damage is graded on a four-point ICRS scale that describes how deeply a lesion penetrates the joint surface. Grade 1 and 2 lesions affect the upper half of the cartilage layer; Grade 3 extends more than halfway through; Grade 4 breaches the subchondral bone beneath. That depth matters because it directly governs how much structural reconstruction is required — and therefore the level of expertise needed.

Defect size is equally important. For focal lesions broadly below 2–4 cm², procedures such as microfracture or mosaicplasty (osteochondral autograft transfer) are within standard orthopaedic competence and remain reasonable first-line choices in appropriate patients. Once a defect reaches approximately 3 cm² or above, the clinical picture changes. The SUMMIT trial demonstrated that defects at this threshold had superior KOOS pain and function scores at both two and five years when treated with MACI — a two-stage, cell-based technique that requires specialist infrastructure, a cell-culture laboratory partner, and precise implantation skills not typically available outside a dedicated centre.

Grade 3–4 lesions introduce further complexity. A full-thickness defect reaching subchondral bone demands a technique that can address the underlying bone as well as the cartilage surface — a combination that narrows the eligible treatment options considerably.

Location adds another layer. Lesions on the posterior femoral condyle, trochlea, or patella carry biomechanical implications — including whether a corrective osteotomy is needed to offload the repair site — that may not be systematically assessed in a general orthopaedic pathway.

Microfracture deserves an honest note: it has played an important historical role, particularly for smaller lesions, but published evidence shows fibrocartilage breakdown by two to three years and potential damage to the subchondral bone plate that can make subsequent specialist repair more difficult. That risk is worth factoring in before committing to a first intervention.

What a cartilage specialist can offer that general practice typically cannot

The most practical way to understand what a specialist centre adds is through the concept of technique matching — selecting the intervention that fits the specific defect, rather than the one most readily available. That matching is only possible when the full range of options is on the table.

At the least invasive end sits the ChondroFiller injection pathway: an ultrasound-guided, outpatient procedure using an injectable collagen scaffold to recruit the patient's own progenitor cells into the repair site. No general anaesthetic is required. For suitable focal defects, this outpatient route represents an access and risk profile that differs substantially from anything theatre-based — and it is not typically available outside a specialist setting.

For defects requiring a surgical approach, single-stage options such as AMIC (matrix-augmented microfracture) and OATS (osteochondral autograft transfer) can address lesions in a single operation. Larger defects — broadly 3 cm² and above, as covered earlier — may call for two-stage cell-based repair such as MACI or ACI, which require a cell-culture laboratory partner and precise re-implantation. For the largest or posttraumatic defects, fresh osteochondral allograft (OCA) transplantation is the appropriate route.

Corrective osteotomy — tibial or distal femoral — sits in a separate category altogether. These procedures address the mechanical load distribution across the joint, not just the defect surface. Where malalignment is contributing to cartilage damage, a repair without correction is likely to fail early. This sub-specialty is seldom available in a general orthopaedic pathway.

Biologic adjuncts such as Arthrosamid serve a different role: as a space-occupying hydrogel, it can reduce mechanical irritation within the joint but does not regenerate cartilage in the way a scaffold repair does. A specialist can assess whether it forms a useful part of a broader plan, rather than position it as a standalone alternative.

The first question worth raising with a specialist is not which technique — it is whether the full range has been considered.

How specialist care is structured differently

For straightforward cartilage presentations — a small focal defect, clear grade, no complicating alignment problem — the standard orthopaedic pathway works well enough. The case for a specialist centre becomes structural when the problem is complex.

General orthopaedic pathways are organised around episodes rather than longitudinal care. A patient with a cartilage problem may encounter a GP, a radiologist, a registrar, and a consultant at separate stages, with no single clinician holding a complete picture of the joint throughout. For a multi-factorial case involving defect morphology, alignment, ligament status, and prior-intervention history, that fragmentation affects the quality of the plan, not just the patient experience.

Dedicated cartilage centres are organised differently: cell biology, medical engineering, imaging interpretation, and surgical delivery sit within one clinical framework, assessed and coordinated by the same specialist from first evaluation through to follow-up. When the clinician who maps the defect also plans and performs the treatment, decision-making draws on contextual knowledge that handoffs between separate clinicians can erode.

The structural tendency to under-refer is a documented pattern. A 2023 Dutch survey found that advanced repair options were offered by only a small minority of knee specialists in routine practice — not because patients had been assessed and found unsuitable, but because those options were never raised. UK referral thresholds are judgment-based rather than protocol-mandated, so access to a specialist assessment often depends on a patient or referring clinician knowing to ask for one.

Finding a cartilage specialist in the UK

Acting on the case for a specialist opinion starts with a GP conversation. Framing the request around joint preservation — specifically, asking whether there are cartilage-repair or non-replacement options worth exploring before a final decision — is a legitimate and reasonable basis for a referral. A second opinion on that question is not an unusual ask.

When evaluating a specialist, the most useful signal is whether cartilage repair or joint preservation appears explicitly as a listed subspecialty, and whether the clinician's practice includes a range of techniques appropriate to different defect sizes and grades. A surgeon who offers only one or two options cannot perform full technique matching, however skilled they are in those methods.

Private referral is also an option for patients who want faster access to a specialist assessment — even if subsequent treatment proceeds through an NHS pathway.

Search MSK is an independent specialist directory that lists cartilage and joint-preservation surgeons across the UK. Using the region and subspecialty filters, patients can identify clinicians whose practice includes the techniques relevant to their situation — and compare options before choosing where to be seen.